comprehensive -WSS

comprehensive

author：explore 2025-10-01 00:48:50 - browse：41283

The FDA building -- First Opinion coverage from STAT — Adobe

The Food and Drug Administration on Thursday released a new accounting of artificial intelligence tools cleared for use in health care, adding scores of new products designed to reshape care in several areas of medicine.

The update included 171 new products that use artificial intelligence and machine learning, including 155 authorized since August of 2022. The agency’s data indicate that, after a lull during the Covid-19 pandemic, the number of authorized devices in 2023 is expected to increase by more than 30% over the prior year.

The list of AI devices was first published after a STAT investigation reported that the FDA had failed to keep the public informed on its regulation of AI devices, or crucial details on the tests undertaken to prove their safety and effectiveness. The summary documents that describe new AI devices often fail to break out the demographics of the patients they were tested on, or where the testing took place, which makes it difficult for clinicians and patients to understand their potential biases and weaknesses.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Is there really a nursing shortage in the U.S.?

hotspot

WSS

Harvard's Jason Buenrostro wins MacArthur grant for genetics work

STAT Readout Newsletter: Biotech news today

ADCs take center stage as promising cancer treatments

Health tech investors get more selective as pandemic boom fades

The future of Biogen: Pragmatism, ‘moonshots,’ and no Twinkies

Why Marc Tessier

hotspot

comprehensive

hotspot

State Dept. review finds Biden bears some blame for Afghanistan failures

Pfizer's RSV vaccine recommended for approval in Europe

Medical records are filled with copy

Family of Gilgo Beach murder suspect releases statement: 'Devastating time'

Medical leaders decry Supreme Court decision on affirmative action

Hey, doctors: Don't be no

Supreme Court strikes down use of affirmative action

J&J lung cancer data amount to new salvo against AstraZeneca

New air purifier tech could be key to improving indoor air quality

What is artificial intelligence? Experts weigh in

entertainment

New chart reveals military’s vast involvement in Operation Warp Speed

STAT Summit: The economic case for universal basic health care

Hey, doctors: Don't be no

UnitedHealth, Optum discontinue NaviHealth name

STAT Readout: Friday, Oct. 20 biotech updates

Hey, doctors: Don't be no

hotspot

entertainment

knowledge

explore